or Try an Advanced Search...

    Technical Analysis for VOR - Vor Biopharma Inc.

    Grade Last Price % Change Price Change
    F 1.87 2.75% 0.05
    VOR closed up 6.43 percent on Monday, April 22, 2024, on 64 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical VOR trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 2.75%
    Oversold Stochastic Weakness 2.75%
    Stochastic Buy Signal Bullish 9.36%
    Wide Bands Range Expansion 9.36%
    Oversold Stochastic Weakness 9.36%
    NR7 Range Contraction 11.31%
    NR7-2 Range Contraction 11.31%
    Wide Bands Range Expansion 11.31%
    Oversold Stochastic Weakness 11.31%
    NR7 Range Contraction 8.09%
    Older End-of-Day Signals for VOR ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 2 hours ago
    Up 3% about 2 hours ago
    Up 2% about 2 hours ago
    Rose Above Previous Day's High about 2 hours ago
    Rose Above 10 DMA about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    VOR Chart by TradingView
    Basic chart:

    Profile

    Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Acute Myeloid Leukemia Tyrosine Kinase Receptors Therapies For Cancer Proteins Haematopoiesis Lintuzumab

    Is VOR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 4 Why You Shouldn't Bet Against Vor Biopharma (VOR) Stock
    Mar 29 Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation
    Mar 20 Vor Biopharma GAAP EPS of -$0.39 beats by $0.11
    Mar 20 Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
    Mar 4 Vor Bio to Participate in Upcoming Investor Conferences
    Feb 17 Institutions own 36% of Vor Biopharma Inc. (NASDAQ:VOR) shares but private equity firms control 43% of the company
    Feb 15 2 “Strong Buy” Penny Stocks That Could Rally All the Way to $10 (or More)
    Feb 7 Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    Jan 19 Vor Bio (VOR) Up on Positive Update From AML Cell Therapy Study
    Jan 17 Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
    See more VOR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.68
    52 Week Low 1.62
    Average Volume 360,657
    200-Day Moving Average 2.29
    50-Day Moving Average 2.04
    20-Day Moving Average 2.00
    10-Day Moving Average 1.85
    Average True Range 0.15
    RSI (14) 43.50
    ADX 17.09
    +DI 17.53
    -DI 23.62
    Chandelier Exit (Long, 3 ATRs) 1.98
    Chandelier Exit (Short, 3 ATRs) 2.11
    Upper Bollinger Bands 2.40
    Lower Bollinger Band 1.61
    Percent B (%b) 0.27
    BandWidth 39.21
    MACD Line -0.09
    MACD Signal Line -0.06
    MACD Histogram -0.0313
    Fundamentals Value
    Market Cap 123.41 Million
    Num Shares 67.8 Million
    EPS -1.89
    Price-to-Earnings (P/E) Ratio -0.96
    Price-to-Sales 0.00
    Price-to-Book 0.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.05
    Resistance 3 (R3) 2.03 1.94 2.01
    Resistance 2 (R2) 1.94 1.88 1.95 2.00
    Resistance 1 (R1) 1.88 1.84 1.91 1.90 1.99
    Pivot Point 1.78 1.78 1.80 1.79 1.78
    Support 1 (S1) 1.72 1.72 1.75 1.74 1.65
    Support 2 (S2) 1.63 1.69 1.64 1.64
    Support 3 (S3) 1.57 1.63 1.63
    Support 4 (S4) 1.59